Arc vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-enhanced browser from The Browser Company; sidebar navigation with Spaces for tab organization and Arc Max AI for page summaries competing against Chrome's dominant market position.
About
Arc is an AI-powered web browser developed by The Browser Company of New York, designed to reinvent the desktop browsing experience with a sidebar-based navigation system, Spaces for organizing tabs by project or context, and AI features (Arc Max) that summarize pages, answer questions about content, and replace common searches — targeting power users and knowledge workers who want a fundamentally better browser than Chrome's tab-per-URL paradigm. Founded in 2019 by Josh Miller and Hursh Agrawal in New York, The Browser Company raised approximately $63 million and launched Arc publicly in 2022.\n\nArc's UI design philosophy departs significantly from Chrome's toolbar-and-tab-bar model: tabs live in a collapsible sidebar, Spaces segment browsing contexts (Work, Personal, Research) so related content stays organized, and archived tabs automatically clear after 12 hours to prevent tab hoarding. Pinned tabs, folders, and a command bar (like Spotlight for the browser) enable keyboard-first navigation. Arc Max AI features include "Ask on Page" (asking questions about the current page without leaving it) and "Instant Links" (skipping search results and going directly to the likely destination).\n\nIn 2025, Arc has built a passionate following among developers, designers, and productivity-focused users but faces the fundamental challenge of displacing Chrome's near-60% browser market share and Google's embedded default browser positioning on Android. The Browser Company announced in 2024 that it would shift focus from Arc to a new AI-native browser product ("Browser for AI era"). Arc competes with Chrome, Firefox, Brave, and Edge for desktop browser share. The 2025 strategy focuses on the next-generation AI browser product while maintaining Arc as a supported product for its existing loyal user base.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.